Back
Amphastar Pharmaceuticals Vs. SELLAS Life Sciences Group Industry Stock Comparison
Buy
53
AMPH
Amphastar Pharmaceuticals
Last Price:
41.00
Seasonality Move:
14.6%
Buy
61
SLS
SELLAS Life Sciences Group
Last Price:
1.54
Seasonality Move:
-7.62%
Buy
53
Amphastar Pharmaceuticals (AMPH)
is a Buy
Is Amphastar Pharmaceuticals a Buy, Sell or Hold?
- The current Amphastar Pharmaceuticals [AMPH] share price is $40.91. The Score for AMPH is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- AMPH is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
SELLAS Life Sciences Group (SLS)
is a Buy
Is SELLAS Life Sciences Group a Buy, Sell or Hold?
- The current SELLAS Life Sciences Group [SLS] share price is $1.63. The Score for SLS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- SLS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AMPH Stock Price Chart
What is Amphastar Pharmaceuticals's stock price today?
-
The Amphastar Pharmaceuticals share price today is $40.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
SLS Stock Price Chart
What is SELLAS Life Sciences Group's stock price today?
-
The SELLAS Life Sciences Group share price today is $1.63
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SLS is experiencing slight buying pressure.
AMPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.51 | Sell |
| Relative Strength Index (14 RSI): | 42.83 | Sell |
| Chaikin Money Flow: | 119483 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (40.1 - 43.52) | Sell |
| Bollinger Bands (100): | (44.19 - 58.69) | Sell |
SLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 73.39 | Buy |
| Chaikin Money Flow: | 618427 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.08 - 1.46) | Buy |
| Bollinger Bands (100): | (0.69 - 1.29) | Buy |
AMPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.14 | Buy |
| 20-day SMA: | 41.24 | Sell |
| 50-day SMA: | 45.62 | Sell |
| 200-day SMA: | 51.81 | Sell |
| 8-day EMA: | 40.34 | Buy |
| 20-day EMA: | 41.38 | Sell |
| 50-day EMA: | 44.85 | Sell |
| 200-day EMA: | 48.45 | Sell |
SLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.46 | Buy |
| 20-day SMA: | 1.33 | Buy |
| 50-day SMA: | 1.16 | Buy |
| 200-day SMA: | 1.18 | Buy |
| 8-day EMA: | 1.49 | Buy |
| 20-day EMA: | 1.37 | Buy |
| 50-day EMA: | 1.2 | Buy |
| 200-day EMA: | 1.27 | Buy |
Amphastar Pharmaceuticals Earnings Growth & AMPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.34 per share, an increase next quarter of $0.06 per share, an increase this year of $0.31 per share, and an increase next year of $0.59 per share.
SELLAS Life Sciences Group Earnings Growth & SLS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.21 per share.
Amphastar Pharmaceuticals Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
SELLAS Life Sciences Group Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||